ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,127.80
0.04%
Gold vs US Dollar
2,298.44
0.01%
Brent Oil
84.135
-0.40%
Bitcoin
60,899.26
0.14%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

  7. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP) News

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NKBP
DateTimeSourceHeadlineSymbolCompany
25/07/201713:00Business WireNantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Pr...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201311:52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201311:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201309:54GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Completion of MergerNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/02/201322:14Edgar (US Regulatory)(25-NSE)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
29/01/201314:16Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
29/01/201314:14Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
29/01/201314:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
18/01/201311:26Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201314:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201314:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201312:28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201312:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201309:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/01/201314:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
17/12/201213:47Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
17/12/201213:47Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
17/12/201213:33Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
17/12/201213:33Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/12/201214:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/11/201213:47Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/11/201213:47Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/11/201211:53Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/11/201211:53Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
25/11/201214:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
13/11/201221:35Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
13/11/201221:35Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
05/11/201213:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/10/201222:00Edgar (US Regulatory)Statement of Ownership: Private Transaction (SC 13E3)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/10/201217:11Business WireRosen Law Firm Announces Investigation of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal from Kin...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:NKBP

Your Recent History

TG
A3K79M
NextEra Energy Capital
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved